Ascendis Pharma A/S: Stifel launches report with a buy rating and a target share price of $200
Ascendis Pharma A/S：Stifel以买入评级和200美元目标股价启动报道
Ascendis Pharma A/S: Stifel launches report with a buy rating and a target share price of $200
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.